NCT00818805

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Accepted

Summary

To evaluate the efficacy of olopatadine 0.1% using the OHIO Chamber in patients with seasonal allergic conjunctivitis.

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	Olopatadine 0.1%	one drop in one eye
DRUG	Tranilast 0.5%	one drop in one eye
DRUG	Placebo (Olopatadine)	one drop in contralateral eye
DRUG	Placebo (Tranilast)	one drop in contralateral eye

Timeline

• Start date: 2008-07-01
• Primary completion: 2008-07-01
• First posted: 2009-01-08
• Last updated: 2012-06-04
• Results posted: 2010-03-15